ask="16.44"
ask_size="800"
average_daily_volume="525502"
bid="10.00"
bid_size="100"
book_value="8.67"
change="+0.48"
change_from_200_day_moving_average="-3.93"
change_from_50_day_moving_average="1.23"
change_from_52_week_high="-30.21"
change_From_52_week_low="4.56"
change_in_percent="+3.31%"
close="14.99"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.69"
ebitda="-118.06M"
eps_estimate_current_year="-3.28"
eps_estimate_next_quarter="-0.78"
eps_estimate_next_year="-2.94"
ex_dividend_date="N/A"
float_shares="34538000"
high="15.02"
high_52_weeks="45.20"
last_trade_date="3/13/2017"
last_trade_price="14.99"
last_trade_size="9033"
last_trade_time="4:00pm"
low="14.40"
low_52_weeks="10.43"
market_capitalization="650.72M"
moving_average_200_day="18.92"
moving_average_50_day="13.76"
name="Intra-Cellular Therapies Inc."
notes="N/A"
one_year_target_price="32.86"
open="14.54"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-20.76%"
percent_change_from_50_day_moving_average="+8.97%"
percent_change_from_52_week_high="-66.84%"
percent_change_from_52_week_low="+43.79%"
previous_close="14.51"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.67"
price_per_sales="1904.67"
revenue="330702.00"
shares_outstanding="43410000"
short_ratio="13.75"
stock_exchange="NMS"
symbol="ITCI"
volume="412645"
weeks_range_52="10.43 - 45.20"
